Viewing Study NCT02747732


Ignite Creation Date: 2025-12-24 @ 9:25 PM
Ignite Modification Date: 2026-03-09 @ 2:03 PM
Study NCT ID: NCT02747732
Status: UNKNOWN
Last Update Posted: 2019-04-23
First Post: 2016-04-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Ibrutinib in Combination With Bendamustine and Rituximab for Patients With Relapsed/Refractory Aggressive BCL
Sponsor: Meirav Kedmi MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module